guanabenz and oxidopamine

guanabenz has been researched along with oxidopamine in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19903 (75.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Healy, DP; Insel, PA; Münzel, PA; Nord, EP; Potenza, CL; Snavely, MD1
Binder, SB; Peach, MJ; Trachte, GJ1
Kubo, T; Misu, Y; Nagura, J1
Aimé, P; Burke, RE; Crary, JF; Dai, D; Greene, LA; Levy, OA; Ramalingam, N; Sun, X1

Other Studies

4 other study(ies) available for guanabenz and oxidopamine

ArticleYear
Radioligand binding and functional assays demonstrate postsynaptic alpha 2-receptors on proximal tubules of rat and rabbit kidney.
    Journal of cardiovascular pharmacology, 1985, Volume: 7 Suppl 8

    Topics: Amiloride; Animals; Autoradiography; Guanabenz; Hydroxydopamines; In Vitro Techniques; Kidney Cortex; Kidney Tubules, Proximal; Kinetics; Male; Oxidopamine; Prazosin; Rabbits; Radioligand Assay; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Yohimbine

1985
Indirect evidence for separate vesicular neuronal origins of norepinephrine and ATP in the rabbit vas deferens.
    European journal of pharmacology, 1989, May-30, Volume: 164, Issue:3

    Topics: Adenosine Triphosphate; Animals; Dinoprostone; Electric Stimulation; Guanabenz; Guanethidine; Hydroxydopamines; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth; Neurons; Neurotransmitter Agents; Norepinephrine; Oxidopamine; Rabbits; Sympatholytics; Vas Deferens

1989
Pharmacological characterization of spinal alpha adrenoceptors related to blood pressure control in rats.
    The Journal of pharmacology and experimental therapeutics, 1987, Volume: 240, Issue:1

    Topics: Adrenergic alpha-Antagonists; Animals; Azepines; Blood Pressure; Brain Stem; Clonidine; Dopamine; Guanabenz; Hydroxydopamines; Injections, Spinal; Male; Norepinephrine; Oxidopamine; Prazosin; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Spinal Cord; Yohimbine

1987
Guanabenz promotes neuronal survival via enhancement of ATF4 and parkin expression in models of Parkinson disease.
    Experimental neurology, 2018, Volume: 303

    Topics: Activating Transcription Factor 4; Adrenergic Agents; Adrenergic alpha-2 Receptor Agonists; Animals; Apoptosis; Cell Death; Disease Models, Animal; DNA Damage; Gene Expression Regulation; Guanabenz; Humans; Mesencephalon; Mice; Mice, Inbred C57BL; Oxidopamine; Parkinson Disease; PC12 Cells; Phosphorylation; Protein Phosphatase 1; Rats; Ubiquitin-Protein Ligases; Up-Regulation

2018